July 31, 2013

Sanofi Appoints Carsten Hellmann and David Meeker to the Executive Committee

 

Sanofi Appoints Carsten Hellmann and David Meeker to the Executive Committee

Paris, France – July 31, 2013 – Sanofi (EURONEXT: SAN and NYSE: SNY) announced today the appointment of two new members to the Executive Committee, effective September 1st, 2013. Carsten Hellmann joins Sanofi from Chr. Hansen Holding A/S and will take the position of Executive Vice President Merial, our Animal Health Division, following the decision of Jose Barella to leave the company to pursue other opportunities. He will be based in Lyon and will sit on the Executive Committee. David Meeker, MD, currently CEO Genzyme and member of the Global Leadership Team, will join the Executive Committee as Executive Vice President, Genzyme.